| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | fkv | PDE2 in complex with compound 7 | 6cyb | 98.71 |
| 2 | fkj | PDE2 in complex with compound 5 | 6cyc | 98.36 |
| 3 | fkg | PDE2 in complex with compound 7 | 6cyd | 97.33 |
| 4 | c6z | PDE2 in complex with molecule 5 | 6ezf | 92.06 |
| 5 | 87r | Crystal structure of human phosphodiesterase 2A in complex with 6-methyl-N-(1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide | 5xkm | 90.77 |
| 6 | czy | Crystal structure of PDE2 in complex with complex 9 | 6b97 | 89.48 |
| 7 | 7y1 | PDE2 catalytic domain complexed with inhibitors | 5u7k | 87.83 |
| 8 | 9gj | Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders | 5vp0 | 87.81 |
| 9 | czv | Crystal Structure of PDE2 in complex with compound 16 | 6b96 | 87.76 |
| 10 | q2t | PDE2a catalytic domain in complex with a brain penetrant inhibitor | 4d08 | 85.64 |
| 11 | ibm | hPDE2A catalytic domain complexed with IBMX | 3itu | 85.32 |
| 12 | 19f | Crystal structure of PDE2 catalytic domain in complex with BAY60-7550 | 4htx | 85.3 |
| 13 | 7y4 | PDE2 catalytic domain complexed with inhibitors | 5u7l | 84.82 |
| 14 | 19f | PDE2 catalytic domain complexed with inhibitors | 5u7d | 84.39 |
| 15 | 9ga | Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders | 5vp1 | 84.3 |
| 16 | dy1 | PDE2 complexed with 2-[6-fluoro-8-methylsulfonyl-9-[(1R)-1-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid | 6blf | 84.13 |
| 17 | eos | Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-isobutoxy-phenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7f | 83.6 |
| 18 | 7ov | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluoro-3-iodophenyl)carbonyl]-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5u00 | 82.69 |
| 19 | 7oy | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-chloro-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzx | 82.38 |
| 20 | 7oj | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzz | 82.37 |
| 21 | 7oj | Crystal Structure of human PDE2a in complex with (5S)-1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzc | 82.24 |
| 22 | 7og | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 3-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl-1-[(naphthalene-2-yl)carbonyl]piperidine | 5tza | 81.51 |
| 23 | 7om | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX with [1,2,4]triazolo[1,5-a]pyrimidin-7-yl}-N-(naphthalene-2-yl)piperidine-3-carboxamide | 5tz3 | 80.89 |
| 24 | 7op | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluorophenyl)carbonyl]-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzh | 80.38 |
| 25 | 7p4 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3,4-difluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine | 5tzw | 80.33 |
| 26 | eog | Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7e | 79.99 |
| 27 | epv | Crystal structure of human phosphodiesterase 2A with 1-(5-tert-butoxy-2-chloro-phenyl)-N-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7j | 79.74 |
| 28 | ep7 | Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-methoxy-phenyl)-N-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7i | 77.68 |
| 29 | eoy | Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7g | 77.65 |
| 30 | 788 | PDE2a catalytic domain in complex with a brain penetrant inhibitor | 4d09 | 77.3 |
| 31 | 1l6 | Crystal structure of of PDE2-inhibitor complex | 4jib | 77.24 |
| 32 | 7xs | PDE2 catalytic domain complexed with inhibitors | 5u7i | 77.23 |
| 33 | 7xv | PDE2 catalytic domain complexed with inhibitors | 5u7j | 76.49 |
| 34 | eoj | Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chlorophenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide | 6c7d | 76.22 |